Janux Therapeutics, Inc.

8-K Other events Jun 23, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Entered a material agreement; Regulation FD disclosure Jan 22, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change Sep 19, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Other events Dec 5, 2024 8-K Regulation FD disclosure; Other events Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change Jul 22, 2024 8-K Shareholder vote results Jun 28, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 8, 2024 8-K Results of operations (earnings release) Mar 8, 2024 8-K Other events Feb 29, 2024 8-K Other events Feb 28, 2024 8-K Other events Feb 27, 2024 8-K Regulation FD disclosure Feb 26, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release); Other events Aug 8, 2023 8-K Entered a material agreement; Other events Jul 18, 2023 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jul 17, 2023